A randomized, placebo-controlled, double-blind trial of mesalamine in the maintenance of remission of Crohn's disease. The Canadian Mesalamine for Remission of Crohn's Disease Study Group
- 1 April 1997
- journal article
- Published by Elsevier in Gastroenterology
- Vol. 112 (4) , 1069-1077
- https://doi.org/10.1016/s0016-5085(97)70117-3
Abstract
No abstract availableKeywords
This publication has 0 references indexed in Scilit: